• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Exclusive-FedEx faces labor union challenge over billionaire CEO’s pay

September 3, 2021 by David Barret Leave a Comment

September 3, 2021

By Jessica DiNapoli

(Reuters) – FedEx Corp shareholders should reject founder and CEO Fred Smith’s $54 million pay package because the logistics company gave him stock options after scrapping a cash bonus in the wake of the COVID-19 pandemic, only to reinstate it later, the Teamsters labor union said on Friday.

Smith, whose net worth is pegged by Forbes at $5.8 billion, was given a special option award “for motivation and retention purposes” in June 2020 after FedEx canceled a $3.4 million cash bonus for him, citing uncertainty around the COVID-19 pandemic.

Those options were worth $6.4 million as of the end of May, the close of FedEx’s fiscal year, more than doubling in value since Smith received them. As more people shipped and received items during the pandemic and FedEx’s business rebounded, the Memphis, Tennessee-based company reinstated Smith’s $3.4 million cash bonus in December, but also allowed him to keep the special stock options.

This amounted to “double-dipping” that undercuts the pay-for-performance structure of Smith’s compensation, the International Brotherhood of Teamsters, which is bargaining on behalf of FedEx employees at a freight facility and is an investor in FedEx through pension and benefit funds, argued in a letter to shareholders on Friday, which was seen by Reuters.

“Having founded the company, been chief executive since 1998 and holding an 8% equity stake, surely CEO Smith has the appropriate incentives to drive shareholder value,” the Teamsters general secretary-treasurer, Ken Hall, wrote in the letter.

The union is urging shareholders to vote against the company’s executive pay plan at the company’s annual meeting on Sept. 27. As with most companies, the vote at FedEx is non-binding.

FedEx declined to comment beyond what it has disclosed on executive pay in securities filings. In its informational disclosure to investors, FedEx said a significant portion of executive compensation is “at risk” and dependent on the company hitting performance goals and share price targets.

FedEx Chief Operating Officer Rajesh Subramaniam, the company’s highest paid executive after Smith, also had his $2 million cash bonus reinstated after he received a similar special option award and stock grant worth approximately $6 million at the end of May.

Many U.S. companies tweaked the pay of executives during the pandemic, easing performance targets and even giving them pay rises. Investors then voted down a record number of CEO pay packages at their annual shareholder meetings earlier this year. [L2N2NL2O2]

Although most shareholder votes on pay are non-binding, some companies have tweaked executive pay when faced with investor opposition. For example, in 2018 Walt Disney Co renegotiated the compensation of its chief executive at the time, Bob Iger, to toughen performance targets after shareholders voted down his pay.

The Teamsters acknowledged in the letter that Smith’s options had yet to vest and that there was still uncertainty over the value of that grant. Smith also accepted a 91% cut in his annual salary during some of the last fiscal year. His salary was $966,125.

(Reporting by Jessica DiNapoli in New York; Editing by Greg Roumeliotis and Leslie Adler)

Source Link Exclusive-FedEx faces labor union challenge over billionaire CEO’s pay

David Barret
David Barret

Related posts:

  1. Taliban prepare to reveal new Afghan government amid economic turmoil
  2. Deutsche Bahn takes striking train drivers’ union to court
  3. Singapore PM wins more defamation suits against bloggers
  4. Vietnam PM warns of long coronavirus fight as crisis deepens

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • Is It True Earth Used To Take 420 Days To Orbit The Sun?
  • One Of The Ocean’s “Most Valuable Habitats” Grows The Only Flowers Known To Bloom In Seawater
  • World’s Largest Digital Camera Snaps 2,104 New Asteroids In 10 Hours, Mice With 2 Dads Father Their Own Offspring, And Much More This Week
  • Simplest Explanation For “Anomalous” Signals Coming From Underneath Antarctica Ruled Out
  • “Lizard Shampoo” And Pagan Texts Suggest “Dark Age” Medicine Wasn’t So Dark After All
  • Japanese Macaques May Mourn Their Dead – As Long As They’re Not Maggot-Infested
  • This Is What You’d Hear If You Listened To Voyager’s Golden Record NASA Sent To Interstellar Space
  • RFK Jr’s New Vaccine Advisors Just Recommended Fall Flu Vaccines – But There’s A Catch
  • Controversial World-First Project To Create Human DNA From Scratch Takes First Steps
  • Humans Weren’t The First Species To Travel Around The Moon. They Lost This Race To An Unexpected Animal
  • When You Hack A Shark, You’re Exploiting A Glitch Billions Of Years In The Making
  • Wellness Whales, A New Blood Type, And A DJ Set From Space
  • Hate Flying Ants? We Used To Have Ones The Size Of Hummingbirds
  • ‘Tis The Season To See Titan Cast A Shadow On Saturn – Especially If You Are In America
  • World’s Bravest Vets Put Full Metal Dental Crown On A Bear For The First Time
  • “Spider Rain”: The Bizarre Phenomenon That’ll Send Arachnophobes Into A Spin
  • Scientists Gave Mice A Human “Language Gene” And Something Curious Unfolded
  • Surveillance Of People Is More “Pervasive And Normalised” Than Previously Thought, Endangering Our Privacy
  • US Sees 90 Percent Drop In Heart Attack Deaths Over Last 50 Years
  • Is A Cat Poop Parasite Decapitating Human Sperm Contributing To Rising Infertility?
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version